Toxicity of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil for advanced head and neck cancer

Israel Medical Association Journal

Volumn 15, Issue 5, 2013, Pages 231-235

  Billan, Salem ^a,c   Kaidar Person, Orit ^a,c   Atrash, Fadi ^a,c   Doweck, Ilana ^b,c   Haim, Nissim ^a,c   Kuten, Abraham ^a,c   Ronen, Ohad ^b,c  

^a Division of Oncology   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

5 fluorouracil (5 FU); Chemotherapy; Cisplatin; Docetaxel; Induction therapy (ICT); Radiotherapy; Squamous cell carcinoma of the head and neck (SCCHN)

Indexed keywords

CETUXIMAB; CIPROFLOXACIN; CISPLATIN; DEXAMETHASONE; DOCETAXEL; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANEMIA; BONE MARROW SUPPRESSION; DIARRHEA; DRUG DOSE REDUCTION; DRUG RESPONSE; ELECTROLYTE DISTURBANCE; EXTERNAL BEAM RADIOTHERAPY; FEBRILE NEUTROPENIA; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX; HYPOPHARYNX CARCINOMA; KIDNEY FAILURE; LETHARGY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; OROPHARYNX; OROPHARYNX CARCINOMA; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PROSPECTIVE STUDY; REVIEW; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPENIA; PROSPECTIVE STUDIES; TAXOIDS;

EID: 84878677677     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Jacobs J, Pajak T, Kinzie J, et al. Induction chemotherapy in advanced head and neck cancer: a Radiation Therapy Oncology Group study. Arch Otolaryngol Head Neck Surg 1987; 113: 193-7.
2. Ensley JF, Jacobs JR, Weaver A, et al. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 1984; 54: 811-14.
3. Pignon JP, le Maitre A, Maillard E, Bourhis J; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14.
4. Posner MR, Hershock DM, Blajman CR, et al; TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007; 57: 1705-15.
5. Vermorken JB, Remenar E, van Herpen C, et al; EORTC 24971/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007; 357: 1695-704.
6. Specenier P, Vermorken JB. Cetuximab in the treatment of squamous cell carcinoma of the head and neck. Expert Rev Anticancer Ther 2011; 11: 511-24.
7. Pointreau Y, Garaud P, Chapet S, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. Natl Cancer Inst 2009; 101: 498-506.
8. http://www.recist.com last accessed on 12.1.2012
9. Bernier J, Domenge C, Ozsahin M, et al; European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-52.
10. Lorch JH, Goloubeva O, Haddad RI, et al; TAX 324 Study Group. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: longterm results of the TAX 324 randomised phase 3 trial. Lancet Oncol 2011; 12: 153-9.
11. Buiret G, Combe C, Favrel V, et al. A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2010; 77: 430-7.
12. Walsh L, Gillham C, Dunne M, et al. Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC). Radiother Oncol 2011; 98: 38-41.
13. Argiris A, Heron DE, Smith RP, et al. Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. J Clin Oncol 2010; 28: 5294-300.
14. Paccagnella A, Mastromauro C, D'Amanzo P, Ghi MG. Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future? Oncologist 2010; 15 (Suppl 3): 8-12.